Article ID Journal Published Year Pages File Type
8235025 International Journal of Radiation Oncology*Biology*Physics 2009 14 Pages PDF
Abstract
Our meta-analysis showed that HDRT is superior to CDRT in preventing biochemical failure in low-, intermediate-, and high-risk prostate cancer patients, suggesting that this should be offered as a treatment for all patients, regardless of their risk status.
Keywords
Related Topics
Physical Sciences and Engineering Physics and Astronomy Radiation
Preview
Higher-Than-Conventional Radiation Doses in Localized Prostate Cancer Treatment: A Meta-analysis of Randomized, Controlled Trials
Authors
, , ,